2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors
- PMID: 12517430
- PMCID: PMC8376400
- DOI: 10.1016/s0968-0896(02)00456-x
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors
Abstract
Structure-activity relationships of 2-phenyl-imidazo[2,1-i]purin-5-ones as ligands for human A(3) adenosine receptors (ARs) were investigated. An ethyl group in the 8-position of the imidazoline ring of 4-methyl-2-phenyl-imidazopurinone leading to chiral compounds was found to increase affinity for human A(3) ARs by several thousand-fold. Propyl substitution instead of methyl at N4 decreased A(3) affinity but increased A(1) affinity leading to potent A(1)-selective AR antagonists. The most potent A(1) antagonist of the present series was (S)-8-ethyl-2-phenyl-4-propyl-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one (S-3) exhibiting a K(i) value of 7.4 nM at rat A(1) ARs and greater than 100-fold selectivity versus rat A(2A) and human A(3) ARs. At human A(1) ARs 2-phenylimidazo[2,1-i]purin-5-ones were generally less potent and therefore less A(1)-selective (S-3: K(i)=98 nM). 2-, 3-, or 4-Mono-chlorination of the 2-phenyl ring reduced A(3) affinity but led to an increase in affinity for A(1) ARs, whereas di- (3,4-dichloro) or polychlorination (2,3,5-trichloro) increased A(3) affinity. The most potent and selective A(3) antagonist of the present series was the trichlorophenyl derivative (R)-8-ethyl-4-methyl-2-(2,3,5-trichlorophenyl)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]purin-5-one (R-8) exhibiting a subnanomolar K(i) value at human A(3) ARs and greater than 800-fold selectivity versus the other AR subtypes. Methylation of 4-alkyl-2-phenyl-substituted imidazo[2,1-i]purin-5-ones led exclusively to the N9-methyl derivatives, which exhibited largely reduced AR affinities as compared to the unmethylated compounds. [35S]GTP gamma S binding studies of the most potent 2-phenyl-imidazo[2,1-i]purin-5-ones at membranes of Chinese hamster ovary cells expressing the human A(3) AR revealed that the compounds were inverse agonists at A(3) receptors under standard test conditions. Due to their high A(3) affinity, selectivity, and relatively high water-solubility, 2-phenyl-imidazo[2,1-i]purin-5-ones may become useful research tools.
Figures




Similar articles
-
Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A(2A)- and A(3)-adenosine receptor antagonists.J Med Chem. 2002 Aug 1;45(16):3440-50. doi: 10.1021/jm011093d. J Med Chem. 2002. PMID: 12139454 Free PMC article.
-
1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.J Med Chem. 2002 Mar 28;45(7):1500-10. doi: 10.1021/jm011049y. J Med Chem. 2002. PMID: 11906291
-
New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.J Med Chem. 2011 Jul 28;54(14):5205-20. doi: 10.1021/jm2004738. Epub 2011 Jun 28. J Med Chem. 2011. PMID: 21675777
-
Medicinal chemistry of adenosine A3 receptor ligands.Curr Top Med Chem. 2003;3(4):445-62. doi: 10.2174/1568026033392174. Curr Top Med Chem. 2003. PMID: 12570761 Review.
-
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists.Curr Pharm Des. 2002;8(26):2285-98. doi: 10.2174/1381612023392856. Curr Pharm Des. 2002. PMID: 12369946 Review.
Cited by
-
Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.J Mol Graph Model. 2006 Dec;25(4):562-77. doi: 10.1016/j.jmgm.2006.05.004. Epub 2006 May 9. J Mol Graph Model. 2006. PMID: 16793299 Free PMC article.
-
Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.Front Chem. 2018 Jun 26;6:206. doi: 10.3389/fchem.2018.00206. eCollection 2018. Front Chem. 2018. PMID: 29998095 Free PMC article.
-
Assay-Dependent Inverse Agonism at the A3 Adenosine Receptor: When Neutral Is Not Neutral.ACS Pharmacol Transl Sci. 2023 Aug 9;6(9):1266-1274. doi: 10.1021/acsptsci.3c00071. eCollection 2023 Sep 8. ACS Pharmacol Transl Sci. 2023. PMID: 37705594 Free PMC article.
-
Pharmacological characterization of DPTN and other selective A3 adenosine receptor antagonists.Purinergic Signal. 2021 Dec;17(4):737-746. doi: 10.1007/s11302-021-09823-5. Epub 2021 Oct 28. Purinergic Signal. 2021. PMID: 34713378 Free PMC article.
-
Progress in the pursuit of therapeutic adenosine receptor antagonists.Med Res Rev. 2006 Mar;26(2):131-59. doi: 10.1002/med.20048. Med Res Rev. 2006. PMID: 16380972 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials